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INTRODUCTION
Aggressive periodontitis (AP) with a prevalence between 
0.1% and 1.0% in European Caucasians, affects a minority 
of patients but is consider as a severe disease regardless the 
serious damage that can lead to early tooth loss.[1,2] The AP 
is characterized by the quick loss of insertion and the bone 
destruction. It usually affects young people who do not 
have a significant medical history and can show a familial 
aggregation of cases.[1-3]
Clinical characteristics of aggressive periodontitis
The AP is less frequent than chronic periodontitis and mainly 
affects young patients, however, it can occur at any age.[3] 
This implies that the etiologic agents have been able to cause 
clinically detectable disease levels in a relatively short period 
of time. This is important for the current understanding of these 
diseases since it involves an infection with a highly virulent 
microflora and/or a high level of the individual susceptibility 
to the AP disease.[3-5]
The environmental factors play a key role in the expression 
of this type of periodontitis. These factors involve tobacco 
smoke (disturbs the relationship between host and parasite 
leading to the worst levels of clinical parameters and limits 
the success of treatment resulting in negative prognosis), oral 
hygiene (although in many cases, the quantity of microbiological 
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ABSTRACT
Periodontal Disease includes a wide variety of infectious entities with various 
clinical manifestations in the oral cavity and responses to treatment. The 
determinants of clinical manifestations of periodontal disease include the type 
of infectious agent, the host immune response and environmental factors. 
Aggressive periodontitis (AP) is defined as a type of inflammation with 
specific clinical and laboratory features, which distinguish it from other types 
of periodontitis, with high incidence rates in a sub-group of individuals. Bacteria 
have been frequently mentioned as the agent inciting gingival inflammation and 
tissue destruction that underlies the pathogenesis of periodontitis. However, 
recent studies, with some controversial results, have suggested that the herpes 
family of viruses, including CMV and EBV-1 as well as papillomaviruses, HIV, 
Human T-lymphotropic virus type 1, Torquetenovirus and hepatitis B and C occur 
with high frequency in active periodontal lesions. There is a lack of information 
about this disease and the role of herpesviruses in its pathophysiology. This 
review provides a critical analysis of the scientific evidence linking bacteria and 
viruses with AP and their potential impact on clinical characteristics, prognosis 
and therapy.
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deposits in the tooth surfaces is inconsistent with the severity 
of periodontal tissue destruction), stress (psychological stress 
appears to be a particularly important trigger of reactivation 
of herpesviruses in immunocompetent subjects),[2,6] 
systemic diseases (diabetes mellitus and obesity) modify the 
inflammatory tissue responses of the host changing the course 
of the AP, some genetic disorders are associated with severe 
periodontitis in children and adolescents, such as neutropenia, 
hypophosphatasia, leukemia, Chediak–Higashi syndrome, 
leukocyte adhesion deficiency, Papillon–Lefevre syndrome, 
trisomy 21, histiocytosis and agranulocytosis.[7-9]
The AP may be localized (LAP) or generalized (GAP) and 
there are common features to both [Table 1] or they can 
differ in many aspects, namely in relation to its etiology and 
pathogenesis.[3,7,10]
Regarding the clinical individual response, the LAP is not 
only a localized way of GAP. [Table 2].
The diagnosis of one of these ways of AP excludes the 
presence of systemic diseases that can severely damage the 
host’s defenses and lead to premature loss of teeth.[9]
The recommended anti-infective treatment for quite some 
time (nonsurgical periodontal treatment/conventional 
or the surgical treatment) is effective in controlling 
the disease progress and the subsequent attempts to 
regenerate some of the lost periodontal tissue are usually 
successful.[11-13] The periodontal support phase designed to 
maximize the effectiveness of the patient’s oral hygiene and 
for the disruption/removal of sub-gingival biofilms at regular 
intervals is absolutely essential to prevent long-time disease 
recurrence.[13]
Pathogens involved in aggressive periodontitis
The current periodontal therapy strongly recommends the 
suppression or eradication of specific pathogens. However, 
it has been difficult to determine the precise role of various 
pathogens involved in the immune response of this disease. 
It is not fully understood why, but in hosts with comparable 
risk factors, some periodontal infections result in loss of 
periodontal attachment and alveolar bone, while in other 
infections, they are limited to gingival inflammation with 
little or no discernible clinical consequences. A low level of 
traditional risk factors is also observed in many aggressive 
periodontal patients.[9,11] It remains an enigma why most 
patients show periodontitis in relatively few teeth despite 
an omnipresence of periodontopathic bacteria in saliva.[14,15] 
Furthermore, many periodontal lesions are self-limiting 
with short-duration morbidity despite a persistent presence 
of periodontopathic bacteria in the periodontal pocket.[14,15] 
Moreover, as clearly evidenced in LAP, periodontal tissue 
destruction tends to occur in a bilaterally symmetrical pattern 
around the midline of the mouth and may almost reach the 
apex in one tooth while barely affecting a neighboring tooth 
sharing the same interproximal space.[14]
Healthy gingival sites harbor a scant microbiota of mainly 
facultative, fermentative, Gram-positive bacteria, whereas 
periodontitis lesions contain predominantly anaerobic, 
proteolytic, Gram-negative species.[15-17] Microbiological 
culture and culture-independent molecular studies have 
identified more than 1200 bacterial species and 18,000 
phylotypes in the oral cavity and at least 400 bacterial species 
in subgingival sites, but despite the long list of different 
bacteria in periodontitis, <20 species are designated major 
periodontal pathogens.[18] The detection and quantification 
of periodontal bacterial species are useful to identify people 
with high-risk periodontitis development, but not consistently 
predict possible future events.[15,17,18]
Even if it is considered that specific infectious agents are 
significantly important in the development of periodontitis, 
it is not likely that a single agent or even a small group of 
pathogens are the unique cause or the modulators of these 
Table 1: Common manifestations of aggressive
periodontitis in localized and generalized forms
Primary manifestations
Medical history not significant
Quick attachment loss and bone destruction
Concentration of family cases
Secondary manifestations
Amounts of microbial deposits inconsistent with the severity of 
periodontal tissue destruction
High proportions of Aggregatibacter actinomycetemcomitans and 
in some populations of the Far East Porphyromonas gingivalis
Phagocytic abnormalities
Phenotypes of hyper-reactive macrophages, including increased 
production of PGE and IL-1β in response to bacterial endotoxin
Progression of attachment loss and bone loss can be stopped
IL-1β: Interleukin-1 beta, PGE: Prostaglandin E
Table 2: Specific manifestations in localized aggressive 
periodontitis and generalized aggressive periodontitis
LAP
Starts peri-pubertal
Intense serum antibody response to infectious agents
Located on the first molar/incisor with interproximal attachment 
loss on at least two permanent teeth, one of the first molar and 
involving no more than two teeth other than first molars and 
incisors
GAP
It affects people under 30 years, but can occur in older patients
Loss of adhesion interproximal affecting at least three permanent 
teeth than the first molars and incisors
Episodic nature with pronounced destruction of the gum insertion 
and alveolar bone
Insufficient serum antibody response to infectious agents
LAP: Localized aggressive periodontitis, GAP: Generalized aggressive 
periodontitis
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heterogeneous diseases.[15,17,18] Currently, it is being accepted 
that AP infections are caused by a diverse microbiota and is not 
caused only by anaerobic Gram-negative bacteria. Because of 
the many puzzling clinical features of periodontitis mostly an 
indirect evidence exists for a bacterial etiology of the disease, 
it is our contention that pure bacterial cause of periodontitis 
has been overemphasized.
Recent studies, with some controversial results, have 
suggested that the herpes family of viruses, including 
human cytomegalovirus (HCMV) and Epstein–Barr virus 
type 1 (EBV-1), papillomavirus, human immunodeficiency 
virus, human T-lymphotropic virus type 1 Torquetenovírus 
and hepatitis B and C occur with high frequency in active 
periodontal lesions.
According to Slots,[19] periodontal destruction may be 
associated with the coexistence of periodontal herpes 
viruses, especially HCMV and EBV, periodontopathogenic 
bacteria and the local impaired host-immune response. AP 
sites presenting HCMV, EBV-1 or herpes simplex virus 
type 1 (HSV-1) had a higher occurrence of Porphyromonas 
gingivalis and Dialister pneumosintes than sites without the 
viruses.[20] Furthermore, AP sites infected with active HCMV 
harbored more Aggregatibacter actinomycetemcomitans than 
sites with latent HCMV infection.[20] Saygun et al.[17] reported 
that HCMV, EBV-1 and HSV-1 were positively associated with 
P. gingivalis, Prevotella intermedia, Tannerella forsythia and 
Campylobacter rectus but not with A. actinomycetemcomitans 
in young adults with advanced periodontitis. The herpes 
viral infection can stimulate the release of cytokines and 
chemokines from inflammatory and noninflammatory cells 
and impair the periodontal immune defense, resulting in more 
virulent resident bacteria.[15,18,19]
The recognition that periodontitis is a multifactorial disease 
that involves the herpes viruses, bacteria and host defense 
reactions may explain why the AP is relatively uncommon in 
the great number of the population despite the high prevalence 
of persons with herpes viruses and periodontal bacteria.
The periodontal pockets infected with herpes viruses tend to 
present greater tissue destruction than the pockets non- infected 
with this virus.[21,22] The active viral herpetic infection is also 
associated with a high risk of progressive periodontal disease.[21]
Viruses reside in high levels within gingival tissue. Saliva can 
contain several additional viruses of medical importance, but 
their relationship to periodontitis has still to be determined.[23,24]
HERPESVIRUSES IN AGGRESSIVE PERIODONTITIS
The occurrence of herpesviruses in this specific type of 
periodontal disease has been studied by qualitative and 
quantitative identification techniques. Table 3 summarizes 
the studies that have been performed until October 2015 
for the presence of human herpes virus (HHV) family, as 
per the tissues/fluids of the oral cavity from where the samples 
were collected, the laboratory method used by the authors, 
the country of origin of the population under study and the 
percentage of positive samples for each herpesvirus.
According to this table, we see that individual lesions of AP 
may yield subgingival herpes viruses as high as 89% for EBV, 
78% for cytomegalovirus, 87% for HSV-1 and 64% for herpes 
virus type 7. The remarkably high copy counts of pathogenic 
viruses in AP lesions make it unlikely that these infectious 
agents are acting merely as harmless bystanders present 
in proportion to the severity of the underlying periodontal 
pathosis.
In Turkey, Saygun et al.[36] detect subgingival HCMV and 
EBV-1 in 72% of AP lesions. In 62 Chinese patients, Ling 
et al.[35] found EBV in 58% of disease-active periodontitis 
sites, but only in 23% of quiescent periodontitis sites. In India, 
Das et al.[26] and Bilichodmath et al.,[28] in 2009 and 2012 found 
similar results for detection of EBV. In Italy,[31] EBV-1 and 
HHV-7 have been related to periodontal disease. Even though 
herpesvirus carriage varies by age, country, region within 
country and population subgroups (e.g., Nibali et al.,[27] in UK, 
and Stein et al.,[25] in Germany, did not detect considerable 
percentage of cytomegalovirus or EBV-1 in their AP patients), 
studies from the various countries report high prevalence of 
this type of viral DNA in AP, attesting to the robustness of 
the herpes-virus-periodontitis association. Kamma et al.[37] 
investigated the occurrence of DNA of HCMV, EBV-1 and 
selected pathogenic bacteria in 16 patients with AP from 
Greece. In each patient, subgingival samples were collected 
from two progressing and two stable periodontitis sites with 
similar depth and gingival inflammation. The study revealed 
that herpesviruses can be detected in some but not in other 
periodontitis lesions of the same individual and even if no 
difference was observed in the level of gingival inflammation, 
herpesviruses occurred more frequently in actively progressing 
than in stable periodontitis sites. Kubar et al.[34] found increased 
periodontal pocket depth and attachment loss in AP sites 
with HCMV presence, compared to periodontitis sites with a 
similar degree of clinical inflammation but with no detectable 
HCMV. Ting et al.[38] studied the relationship between HCMV 
activation and disease-active versus disease-stable AP in 
11 patients between the ages of 10 and 23 years. The presence 
of messenger RNA of the HCMV major capsid protein, which 
is an indication of an active HCMV infection, was detected 
in deep pockets of all five HCMV-positive patients with 
early disease (aged 10–14 years), but only in one of three 
HCMV-positive patients older than 14 years and not in any 
shallow test sites. The study found HCMV reactivation in 
some and HCMV latency in other periodontal sites of the same 
patient, pointing to site-specificity in oral HCMV transcription 
state. Gingiva of AP lesions tends to show high levels of 
T-suppressor cells and Langerhans cells which are potential 
carriers of the HCMV genome.[41]
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Concerning the present results, we have observed important 
differences in the percentage of prevalence of genomic 
viral DNA, among the papers analyzed. The sampling 
methods are similar and standardized. The polymerase 
chain reaction (PCR) analysis is the method of choice for 
the detection of viral DNA. However, because of high assay 
sensitivity, PCR may detect herpesviruses at copy counts 
too low to be of clinical significance.[42] As low herpesvirus 
counts occur more frequently in healthy or slightly inflamed 
periodontal sites[42] than in periodontitis lesions, PCR-based 
studies may disproportionately overestimate the significance 
of herpesviruses in normal periodontal sites. False negative 
PCR results may be caused by failure to sample gingival 
epithelial cells rich in EBV[43] or by an inhibitory effect of 
components of the amplification process. Dissimilar inclusion 
criteria for the study of individuals and sample sites are 
probably the main reasons for differences in the detection rate 
of periodontal herpesviruses.[42] It is important to investigate 
Table 3: Studies concerning prevalence of herpesviruses in aggressive periodontitis, according to locations of 
sampling, study populations and laboratory methods
Authors/country Collection site of the samples Laboratorial methods Herpesvirus (% prevalence)
Stein et al. (2012)/Germany[25] Sub-gingival plaque PCR real time HSV-1 (1.5)
EBV (10.8)
Cytomegalovirus (1.5)
Das et al./India[26] Sub-gingival plaque PCR multiplex HSV-1 (80)
EBV (32)
Saygun et al./Turkey[24] Saliva PCR real time EBV (60)
Nibali et al./UK[27] Sub-gingival plaque PCR real time EBV (9)
Cytomegalovirus (0)
Bilichodmath et al./India[28] Sub-gingival plaque PCR multiplex HSV-1 (57)
EBV (29)
Cytomegalovirus (7)
Imbronito et al./Brazil[29] Sub-gingival plaque Nested PCR HSV-1 (87)
EBV (33)
Cytomegalovirus (47)
Botero et al./Colombia[30] Gingival crevicular fluid Nested PCR
PCR real time
Viral culture
Cytomegalovirus (48)
Rotola et al./Italy[31] Biopsy of the gingival 
periodontal pocket
Nested PCR EBV (55)
Herpes virus type 7 (64)
Saygun et al./Turkey[17] Sub-gingival plaque PCR real time EBV (60)
Cytomegalovirus (53)
Ding et al./China[32] Sub-gingival plaque Nested PCR Cytomegalovirus (44)
Botero et al./Colombia[21] Sub-gingival plaque Nested PCR Cytomegalovirus (40)
Watanabe et al./Brazil[33] Gingival crevicular fluid PCR EBV (57)
Cytomegalovirus (7)
Kubar et al./Turkey[34] Biopsy of the gingival 
periodontal pocket
PCR real time EBV (89)
Cytomegalovirus (78)
Ling et al./Taiwan[35] Sub-gingival plaque Nested PCR EBV (58)
Saygun et al./Turkey[36] Sub-gingival plaque PCR HSV-1 (78)
HSV-2 (17)
EBV (72)
Cytomegalovirus (72)
Kamma et al./Greece[37] Sub-gingival plaque Nested PCR HSV-1 (34)
EBV (44)
Cytomegalovirus (59)
Ting et al./USA[38] Gingival crevicular fluid Nested PCR HSV-1 (54)
EBV (63)
Cytomegalovirus (72)
Dani et al./India[39] Gingival biopsies PCR real time HSV-1 (47)
EBV (67)
Cytomegalovirus (53)
Grigoras et al./Romania[40] Sub-gingival plaque PCR real time HSV-1 (78)
EBV (72)
Cytomegalovirus (72)
PCR: Polymerase chain reaction, HSV-1: Herpes simplex virus type 1, EBV: Epstein-Barr virus
Herpes virus and aggressive periodontitis Rodrigues, et al. 352 
Journal of Oral and Maxillofacial Pathology: Vol. 19 Issue 3 Sep - Dec 2015
periodontitis lesions that are actively progressing or, at very 
least, have not recently received professional treatment. The 
characteristic latency between the herpes virus may also 
explain some more discrepant results since it is not known if 
the disease is active at the time of sampling or if the herpes 
virus family were present at an earlier stage of the disease.
For the study populations, most studies have been performed 
in South America, China, Turkey, or African Americans 
(those populations have many ethnic groups) and there 
are few studies to be performed in Caucasians. In those, 
periodontal cytomegalovirus and EBV have been found at low 
prevalences in some, but not in all European countries with a 
predominantly Caucasian population.[42] In terms of number of 
persons with AP disease which have been the samples, there 
have been studies that used from 11 persons to 140 persons.
The main purpose of studies on periodontal herpesviruses 
is eventually to prevent or cure periodontitis by 
controlling the viruses. Further progress in delineating the 
periodonto-pathogenicity of herpesviruses depends on the use 
of well-defined periodontal disease and control populations, 
sufficiently large study groups, validated molecular detection 
methods.
Pathways of interaction between herpes virus 
and bacteria in the development of aggressive 
periodontitis
The evidence supports the hypothesis of co-infection in 
which the development and progress of periodontal disease 
are associated with the infection of active herpesviruses, in 
conjunction with opportunistic pathogenic bacteria living in 
the endogenous sub-gingival microbiota.[18,19] The theorized 
events for this association could now have several scenarios.
One is that the herpes virus infection results in increased 
local pro-inflammatory cytokines that subsequently break 
the homeostatic balance between the existing periodontal 
microbiota and the host. Members of this sub-gingival 
microbiota that take advantage of the inflammatory 
conditions (e.g. P. gingivalis, T. forsythia and Treponema spp.) 
proliferate and help in the development and progress of 
periodontitis.[19,41] Another interesting hypothesis is that the 
proposed primary cytomegalovirus infection acting during 
the formation of the tooth root and then when there is 
reactivation during puberty, this virus may be involved in the 
pathogenesis of  LAP. This may lead to malformation of the 
initial periodontal attachment apparatus and may partially 
explain why there is a minimum amount of bacterial plaque 
in the early stages of LAP.[15,19,41]
Herpesviruses target various cells of the immune system 
and subvert host immune functions to their own advantage. 
It is known that cytomegalovirus infects periodontal 
monocytes/macrophages and T lymphocytes and EBV infects 
periodontal B lymphocytes. These infected inflammatory 
cells stimulate tissue destructive cytokines and decrease the 
defensibility against periodontal bacteria.[16,19,41]
The host immune response attempts to control both viruses 
and bacteria in periodontal pockets. However, it is not clear 
whether some inflammatory mediators such as cytokines 
and some chemokines play a primary role of protection or 
destruction in periodontal disease.[9,14] On the other hand, 
some immune mechanisms that are active against viruses may 
decrease the antibacterial immune response and vice versa. It 
may be possible that periodontitis is the result of extensive or 
partial responses opposite against combined viral-bacterial 
infections.[15,18-20]
The discovery of abundant herpesviruses in periodontal 
lesions redefines the pathogenic paradigm and inflammatory 
periodontal disease. In Figure 1, we can observe a potential 
model of development of periodontitis by a sequential 
infectious process, adapted from Slots.[19]
Initially, the biofilm bacteria induce gingivitis which allows 
latent herpes virus, embedded in DNA of macrophages, 
T lymphocytes and B lymphocytes to infiltrate the periodontium. 
Cytomegalovirus, for example, can be replicated in the gum 
tissue which may help to keep the periodontal infection. The 
reactivation of latent herpes virus may occur spontaneously 
or during periods of decreased host defenses, through 
immunosuppression induced by drugs, concomitant infection, 
prolonged emotional stress, hormonal changes, trauma, etc. 
Some of the factors involved in herpes virus activations are 
also risk indicators for the periodontitis.[19,41]
In response to the active herpes virus infection, the host 
starts a strong immune response mediated by T cells, namely 
CD8+ T cells. To counteract this hostile environment created 
by the host, the herpes virus try strategies to reduce anti-viral 
Figure 1: Infection model for the development of periodontitis (Modified 
from Slots J. Herpesviruses in periodontal diseases. Periodontol 2000 
2005;38:33-62)
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defense: They disintegrate major histocompatibility complex 
components and interfere with antigen presentation, silencing 
natural killer cells expressing a viral homolog of interleukin-10 
and inhibiting the apoptosis. This clash between the host 
antiviral defense and anti-viral host response results in a great 
release of pro-inflammatory cytokines that have the potential to 
activate osteoclasts and inhibit the action of antibodies against 
bacteria such as P. gingivalis and A. actinomycetemcomitans. 
Then, the activation of known mechanisms involved in 
periodontal destruction, inflammation, collagen degradation 
and osseous resorption can be observed.[19,41]
Cytomegalovirus and other herpes viruses can promote 
pathological effects on fibroblasts, epithelial cells, 
keratinocytes, endothelial cells, inflammatory cells and bone 
cells. They can take part in the degradation of collagen and 
interfere with the cell turnover and the healing process in 
periodontal guided tissue regeneration.[19,41]
The propensity for local tropism of herpes virus may explain 
the pattern of periodontal tissue destruction which may differ 
from tooth to tooth in the same patient or from surface to 
surface in one tooth.[19,41]
The destruction of periodontal tissue may be depending 
on the simultaneous occurrence of a number of infectious 
pathological events that include a sufficient existence of 
herpes virus in periodontal tissue, activation of herpes 
virus in the periodontium, inadequate protective antiviral 
response of cytotoxic T lymphocytes, the presence of 
specific periodontal pathogenic bacteria and inadequate 
antibodies that are a protective response to the presence of 
certain bacteria.[19,41]
The interactions between herpes virus and bacteria may 
explain some characteristics of the destructive periodontal 
disease. The alternation between periods with long latency 
with periods of activation of viral infections may be 
partially responsible for episodes of disease exacerbation. 
The absence of herpes virus infection or viral reactivation 
may clarify why some persons are carriers of periodontal 
bacteria and present minimal signs of periodontal 
inflammation.
THERAPEUTIC IMPLICATIONS
The conventional nonsurgical periodontal therapy reduces 
the viral existence of herpes viruses.[13] The scaling and root 
planning remove genomic copies of cytomegalovirus, EBV 
and herpes virus type 7 until none detectable in sub gingiva 
and saliva.[12,13] The decrease posttreatment of the herpes virus 
counting is probably due to the reduction of gingivitis and 
consequently to the number of infected inflammatory cells.[19] 
Similarly, the low counting of herpes virus in periodontal 
healthy areas may be the result of the absence of inflammatory 
cells infected on them.[19]
The treatment of AP includes regular systemic antibiotics; not 
only because of the mechanical limitations that conventional 
treatment presents (some specific bacteria can be reduced 
but not all, negative consequences such as recession gum 
and tooth hypersensitivity after scaling and root planing 
and difficulty in reaching microbiological niche) but also 
by the specific characteristics of this kind of periodontitis. 
Thus, antibiotics should be used as helpers to conservative 
mechanical treatment, never as monotherapy and the best 
results are obtained when the taking is immediately after the 
last root planning. The dose demonstrated to be more effective 
refers to amoxicillin/metronidazole (375 mg ± 250 mg/8–8 h) 
or clindamycin (300–600 mg/6–6 h).[44]
The saliva may contain a high number of herpesviruses 
(EBV, cytomegalovirus and herpes virus 6 and 7) and conventional 
periodontal treatment can reduce the number of genomic copies 
in this fluid.[23,24] Some studies suggest that periodontal pockets 
are the major source of salivary herpes.[23,24] This potential of the 
conventional periodontal therapy in reducing the salivary viral 
levels may be helpful in reducing the risk of viral transmission 
and disease related to these micro-organisms.[42]
Marked reduction or eradication of herpesviruses in 
periodontal sites may improve not only the periodontal health 
status, but also decrease the frequency of herpesvirus viremia 
and salivary transmission and perhaps lower the risk of serious 
medial diseases and disabilities.[42]
Microbiological tests may be repeated 1–3 months after the 
completion of the therapy to verify the elimination or marked 
suppression of pathogens. After resolution of the periodontal 
infection, the patient should be placed on a periodontal 
maintenance program, which shall include the continuous 
evaluation of the occurrence and risk of disease progress, 
every 3 months.[12,13]
The infectious model of bacteria/viruses of the AP allows 
new considerations in the prevention and treatment of 
the disease, for example, treatment with anti-viral drugs, 
namely with valacyclovir 500 mg, 2 times daily for 10 days 
(anti-herpes drug).[45]
CONCLUSIONS
We intend with this work to summarize the evidence linking 
herpes viruses to the development of AP and elucidate 
the potential mechanisms, through which herpes viruses 
contribute to the breaking of periodontal tissue defenses. It 
has been suggested that the coexistence of these viruses and 
possibly of other viruses with periodontal bacteria and host 
immune responses can be seen as a precarious balance that has 
the potential to lead to periodontal destruction.
Nevertheless, despite a large body of compelling research data, 
definitive proof is still lacking that periodontal herpesviruses 
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play a causal role in periodontitis development and do not 
occur merely as an epiphenomenon to the periodontal disease 
process.
The etiopathogenesis of AP includes virulent factors of herpes 
virus and bacteria, host immune responses against viruses and 
bacteria and manipulation of host cellular processes by the 
infectious agents. Herpes viruses can induce periodontitis by 
activating channels of the specific destructive immune system 
and by placing the person in the hands of increased bacterial 
existence. However, the molecular contribution of the 
herpes virus versus bacteria in AP is still poorly understood. 
Potential factors of immunosuppression are trigger points 
for the viral reactivation and perhaps a risk factor for the 
periodontal disease. Herpes viruses are strong inducers of 
pro-inflammatory cytokines that have the capacity to activate 
osteoclasts and matrix metalloproteinases. Some periodontal 
bacteria can reactivate a latent herpes virus. The synergy 
between these viruses and bacteria in the periodontal tissue 
may play an important role in the advance and progress of AP.
Understanding the pathophysiology of periodontal herpes 
viruses may help to outline the molecular determinants that 
cause gum disease that progresses to periodontitis or stable 
periodontitis which become a progressive disease. Evidence 
of a causal role of herpes viruses in periodontitis could be the 
basis of new strategies for diagnosis, prevention and treatment 
of this disease.
The development of vaccines for herpes virus in the medium 
term would likely be an important victory for the maintenance 
of conditions favorable/stable to the aggressive periodontal 
disease that does not allow the disease to advance, reducing 
the role of conventional periodontal therapy or surgery and 
antibiotics. Conclusive evidence of an etiologic role for 
herpesviruses in periodontitis will probably have to await the 
development of effective herpesvirus vaccines.
Increased research into periodontal virology is encouraged given 
the remarkable preventive and curative possibilities it may offer.
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